Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes

---

Original Article

Author Details : Akshay Dahiwele, Dinesh Kansal, Dheeraj Kapoor, Parveen Sharma

Volume : 3, Issue : 1, Year : 2018

Article Page : 10-12

https://doi.org/10.18231/2456-9542.2018.0003

Suggest article by email

Get Permission

---

Abstract

Introduction: Diabetes is characterized by chronic hyperglycemia and disturbances of carbohydrate, lipid and protein metabolism. This study is an attempt to show an improvement in lipid profile (TC, TG, LDL and HDL) in patients of type 2 diabetes mellitus who were previously on metformin monotherapy with uncontrolled diabetes.
Material and method: A total of 30 patients were enrolled who were on metformin monotherapy and with uncontrolled diabetes. Patients were given metformin 500 mg twice a day and saxagliptin 2.5 mg once a day.
Patients were followed up at 1^st, 3^rd and 6^th month and lipid profile (TC, TG, LDL and HDL) estimation was done during the follow up period.
Results: The mean age ± SD in male and female patients was 61.42 yrs ± 6.99 and 55.93 yrs ± 5.74 respectively. The mean change in value from baseline at 24 weeks was TC = 9.66%, TG = 9.40%, LDL = 14.87%, HDL = 5.63%. A highly significant difference has been seen at 0 v/s 1, 0 v/s 3 and 0 v/s 6 months in TC, TG, LDL and HDL values.
Conclusion: Saxagliptin has shown an improvement in lipid profile (TC, TG, LDL, HDL) during 6 months of treatment in patients of type 2 DM.

Keywords: Saxagliptin, Uncontrolled type 2DM, Metformin, Lipid profile.

How to cite : Dahiwele A, Kansal D, Kapoor D, Sharma P, Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes. Indian J Clin Anat Physiol 2018;3(1):10-12

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.